Diversified Trust’s PTC Therapeutics PTCT Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $773K | Sell |
15,833
-1,314
| -8% | -$64.2K | 0.02% | 450 |
|
2025
Q1 | $874K | Buy |
17,147
+329
| +2% | +$16.8K | 0.02% | 408 |
|
2024
Q4 | $759K | Buy |
16,818
+1,578
| +10% | +$71.2K | 0.02% | 458 |
|
2024
Q3 | $565K | Sell |
15,240
-77
| -0.5% | -$2.86K | 0.01% | 558 |
|
2024
Q2 | $468K | Buy |
15,317
+818
| +6% | +$25K | 0.01% | 556 |
|
2024
Q1 | $422K | Buy |
14,499
+295
| +2% | +$8.58K | 0.01% | 554 |
|
2023
Q4 | $391K | Buy |
14,204
+896
| +7% | +$24.7K | 0.01% | 573 |
|
2023
Q3 | $298K | Buy |
13,308
+318
| +2% | +$7.13K | 0.01% | 619 |
|
2023
Q2 | $528K | Buy |
12,990
+695
| +6% | +$28.3K | 0.02% | 446 |
|
2023
Q1 | $596K | Buy |
12,295
+3,806
| +45% | +$184K | 0.02% | 406 |
|
2022
Q4 | $324K | Sell |
8,489
-9
| -0.1% | -$344 | 0.01% | 555 |
|
2022
Q3 | $427K | Buy |
8,498
+422
| +5% | +$21.2K | 0.02% | 442 |
|
2022
Q2 | $324K | Sell |
8,076
-49
| -0.6% | -$1.97K | 0.01% | 538 |
|
2022
Q1 | $303K | Sell |
8,125
-252
| -3% | -$9.4K | 0.01% | 614 |
|
2021
Q4 | $334K | Buy |
+8,377
| New | +$334K | 0.01% | 601 |
|
2020
Q4 | – | Sell |
-6,064
| Closed | -$283K | – | 774 |
|
2020
Q3 | $283K | Sell |
6,064
-243
| -4% | -$11.3K | 0.01% | 466 |
|
2020
Q2 | $320K | Buy |
+6,307
| New | +$320K | 0.02% | 372 |
|
2015
Q1 | – | Sell |
-4,015
| Closed | -$208K | – | 509 |
|
2014
Q4 | $208K | Buy |
+4,015
| New | +$208K | 0.02% | 472 |
|